Transforming Scientific Complexity into Confident, Evidence-Backed Action
Founded in 2020, Pienomial is transforming how life sciences organizations accelerate innovation, reduce risk, and scale drug development. Our mission: enable a healthier world through smarter, faster, and fully evidence-based decision-making across the therapeutic lifecycle.
We empower pharmaceutical companies, biotechnology innovators, CROs, and life sciences consulting firms to transform unstructured biomedical data into traceable, actionable intelligence. Knolens supports evidence-driven decision-making across clinical development, market access, regulatory strategy, HEOR, medical affairs, and competitive intelligence.
Clinical Development , Health Economics and Outcomes Research (HEOR), Market Access & Payer Strategy, Regulatory Intelligence, Medical Affairs Value & Evidence Modeling
At the heart of Pienomial is Knolens, our proprietary AI-powered intelligence platform. Designed with scientific integrity in mind, Knolens delivers:
Pienomial, 1 Research Court, Suite 450, Rockville, MD 20850
2nd Floor, B Wing, FQQV+G38 Highway Height, Atul Nagar, Warje, Pune, Maharashtra 411058
Pienomial is an AI LifeScience company that transforms how professionals access and analyze data in support of their business goals. Whether you are in Big Pharma or a small biotech; or a service provider to the industry Pienomial can help you in a range of functions in your business.
Knolens is our flagship platform that leverages advanced AI to extract real-time, accurate insights from clinical trials, scientific publications, and other data sources in the life sciences domain.
Knolens, through its AI-driven analysis, helps streamline product development and enhance decision-making—empowering researchers, developers, and strategists in life sciences to stay ahead in a competitive and fast-evolving industry.
Knolens uses a combination of multiple techniques including automated AI pipelines, human verification and domain expertise to ensure high relevance, accuracy and reliability of the data used in the analysis.
Knolens can easily integrate and analyze a wide range of structured and unstructured information including but not limited to PubMed, EMA databases, and scientific journals, financial reports and other data sources. Our customers can also optionally choose to leverage the power of our platform with their internal knowledge bases and data sources.
Yes, the Knolens platform is built for modularity and configurability. Our customers choose to use it in a way that provides them unique benefits specific to their business goals while leveraging the power of a stable, proven platform.